Animal nutrition company Novus International has responded to Highly Pathogenic Avian Influenza (HPAI) outbreaks by redefining the delivery protocols and biosecurity procedures.
HPAI broke out earlier this year, and producers throughout the United States altered and heightened their on-farm biosecurity measures to prevent outbreaks. HPAI can cause high mortality in commercial poultry flocks and can be transmitted in various ways, often through direct contact between a healthy bird and an infected bird or its secretions and faecal material. It can also be transmitted by humans and equipment that have been in contact with infected material.
The customer supply chain organisation at Novus International, Inc. quickly responded to all specific requests from customers receiving bulk Alimet and Santoquin deliveries who called for increased biosecurity procedures. Then, they decided to take it a step further and alter their delivery biosecurity procedures.
“We elected to be proactive and let our customers know we were taking steps to help protect their business. If customers request specific procedures above and beyond our revised measures, we will do our best to comply,” says Rick Kasmarick, Executive Manager, Novus North America Customer Supply Chain.
The North America Customer Supply Chain organisation has further refined delivery protocols this fall, and biosecurity procedures are continuing to be implemented by Novus to prevent the chance of spreading of HPAI or any other disease. Novus’s response to current and future outbreaks is implementation of the following biosecurity procedures:
"*" indicates required fields
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (18) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.